Minimal residual disease (MRD) detection with circulating tumor DNA (ctDNA) from personalized assays in stage II-III colorectal cancer patients in a UK multicenter prospective study (TRACC)

被引：23

作者：

Anandappa, Gayathri ^{[1
]}

Starling, Naureen ^{[2
,3
]}

Begum, Ruwaida ^{[4
,5
]}

Bryant, Annette ^{[4
,5
]}

Sharma, Shruti ^{[6
]}

Renner, Derrick ^{[6
]}

Aresu, Maria ^{[5
]}

Peckitt, Clare ^{[4
,5
]}

Sethi, Himanshu ^{[6
]}

Feber, Andrew ^{[7
]}

Potter, Vanessa Alice ^{[8
]}

Paraoan, Marius ^{[9
]}

Abulafi, Muti ^{[10
]}

George, Nicol ^{[11
]}

Branagan, Graham ^{[12
]}

Duff, Sarah ^{[13
]}

West, Nicholas ^{[14
]}

Aleshin, Alexey ^{[6
]}

Chau, Ian ^{[15
]}

Cunningham, David ^{[16
]}

机构：

[1] Royal Marsden NHS Fdn Trust, London, England

[2] Royal Marsden Hosp NHS Fdn Trust, London, England

[3] Royal Marsden Hosp NHS Fdn Trust, Surrey, England

[4] Royal Marsden NHS Fdn Trust, London, England

[5] Royal Marsden NHS Fdn Trust, Surrey, England

[6] Natera Inc, San Carlos, CA USA

[7] Inst Canc Res, Sutton, Surrey, England

[8] Univ Hosp Coventry & Warwickshire, Coventry, W Midlands, England

[9] Wigan & Leigh NHS Fdn Trust, Wigan, England

[10] Croydon Univ Hosp, London, England

[11] Southend Univ Hosp, Westcliff On Sea, Essex, England

[12] Salisbury NHS Fdn Trust, Salisbury, Wilts, England

[13] Manchester Univ NHS Fdn Trust, Manchester, Lancs, England

[14] Epsom & St Helier NHS Fdn Trust, Epsom, Surrey, England

[15] Royal Marsden Hosp NHS Fdn Trust, London, England

[16] Royal Marsden Hosp, Sutton, Surrey, England

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 03期

关键词：

D O I：

10.1200/JCO.2021.39.3_suppl.102

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

102

引用

页数：2

共 50 条

[31] Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Tie, Jeanne
Wang, Yuxuan
Tomasetti, Cristian
Li, Lu
Springer, Simeon
Kinde, Isaac
Silliman, Natalie
Tacey, Mark
Wong, Hui-Li
Christie, Michael
Kosmider, Suzanne
Skinner, Iain
Wong, Rachel
Steel, Malcolm
Tran, Ben
Desai, Jayesh
Jones, Ian
Haydon, Andrew
Hayes, Theresa
Price, Tim J.
Strausberg, Robert L.
Diaz, Luis A., Jr.
Papadopoulos, Nickolas
Kinzler, Kenneth W.
Vogelstein, Bert
Gibbs, Peter
[J]. SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (346)
[32] Analysis of circulating tumor DNA after neoadjuvant therapy to predict disease relapse in patients with stage II-III breast cancer
Lin, Po-Han
Kuo, Sung-Sheng
Huang, Chiun-Sheng
[J]. CANCER RESEARCH, 2020, 80 (16)
[33] Performance characteristics of a tumor-informed circulating tumor DNA (ctDNA) minimal residual disease (MRD) assay in invasive bladder cancer in clinical practice.
Mehler, Shoshana
Guilbeau, Seth
Somer, Shmuel
Reed, Kevin
Greene, Heather
Vaena, Daniel A.
Grothey, Axel
Somer, Brad
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
[34] Detection of molecular residual disease in stage II and III melanoma utilizing circulating tumor DNA.
Chen, Emily
Brunsgaard, Elise Kornreich
Kuzel, Timothy
Tan, Alan
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[35] Comparing single-target and multitarget approaches for postoperative circulating tumour DNA detection in stage II-III colorectal cancer patients
Henriksen, Tenna Vesterman
Reinert, Thomas
Rasmussen, Mads Heilskov
Demuth, Christina
Love, Uffe Schou
Madsen, Anders Husted
Gotschalck, Kare Andersson
Iversen, Lene Hjerrild
Andersen, Claus Lindbjerg
[J]. MOLECULAR ONCOLOGY, 2022, 16 (20) : 3654 - 3665
[36] Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences
Henriksen, Tenna Vesterman
Tarazona, Noelia
Frydendahl, Amanda
Reinert, Thomas
Gimeno-Valiente, Francisco
Antonio Carbonell-Asins, Juan
Sharma, Shruti
Renner, Derrick
Hafez, Dina
Roda, Desamparados
Huerta, Marisol
Rosello, Susana
Madsen, Anders Husted
Love, Uffe S.
Andersen, Per Vadgaard
Thorlacius-Ussing, Ole
Iversen, Lene Hjerrild
Gotschalck, Kare Andersson
Sethi, Himanshu
Aleshin, Alexey
Cervantes, Andres
Andersen, Claus Lindbjerg
[J]. CLINICAL CANCER RESEARCH, 2022, 28 (03) : 507 - 517
[37] Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases
Loupakis, Fotios
Sharma, Shruti
Derouazi, Madiha
Murgioni, Sabina
Biason, Paola
Rizzato, Mario Domenico
Rasola, Cosimo
Renner, Derrick
Shchegrova, Svetlana
Malashevich, Allyson Koyen
Malhotra, Meenakshi
Sethi, Himanshu
Zimmermann, Bernhard G.
Aleshin, Alexey
Moshkevich, Solomon
Billings, Paul R.
Sedgwick, Jonathon D.
Schirripa, Marta
Munari, Giada
Cillo, Umberto
Pilati, Pierluigi
Dei Tos, Angelo Paolo
Zagonel, Vittorina
Lonardi, Sara
Fassan, Matteo
[J]. JCO PRECISION ONCOLOGY, 2021, 5 : 1166 - 1177
[38] Circulating tumor DNA is a prognostic marker of tumor recurrence in stage II and III colorectal cancer: multicentric, prospective cohort study (ALGECOLS)
Benhaim, Leonor
Bouche, Olivier
Normand, Corinne
Didelot, Audrey
Mulot, Claire
Le Corre, Delphine
Garrigou, Sonia
Djadi-Prat, Juliette
Wang-Renault, Shu-Fang
Perez-Toralla, Karla
Pekin, Deniz
Poulet, Geoffroy
Landi, Bruno
Taieb, Julien
Selvy, Marie
Emile, Jean-Francois
Lecomte, Thierry
Blons, Helene
Chatellier, Gilles
Link, Darren R.
Taly, Valerie
Laurent-Puig, Pierre
[J]. EUROPEAN JOURNAL OF CANCER, 2021, 159 : 24 - 33
[39] Detection of minimal residual disease (MRD) in colorectal cancer (CRC) patients UICC stage II/III by ultra-deep sequencing of cfDNA from post-surgery plasma
McNamara, Sylvie
Patel, Rajesh D.
Adams, Hans-Peter
Qu, Xueping
Hinzmann, Bernd
Wong, Cheryl V.
Heilek, Gabrielle
Mantke, Rene
Heise, Michael
Steinmueller, Thomas
Pross, Matthias
Marusch, Frank
Bais, Carlos
Palma, John F.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
[40] Novel circulating tumor DNA (ctDNA) based ddPCR drop-off assays for improved Minimal Residual Disease (MRD) monitoring in Acute Myeloid Leukemia (AML)
Rausch, C.
Ziemann, F.
Schneider, S.
Subklewe, M.
Spiekermann, K.
Rothenberg-Thurley, M.
Metzeler, K. H.
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 252 - 252

← 1 2 3 4 5 →